News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Solvay SA’s Operating Results (EUR 925 million) 5% Above the Excellent Results from the First 9 months of 2006 (+8% in the 3rd quarter)
October 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, BELGIUM--(Marketwire - October 26, 2007) - Embargo: Brussels, October 26, 2007 at 7:30 AM Solvay's operating results (EUR 925 million) 5% above the excellent results from the first 9 months of 2006 (+8% in the 3rd quarter)
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
Roche Makes Major MASH Move With $3.5B 89bio Buy
September 18, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Arsenal, X4 Lay Off Half of Staff to Cut Costs
September 18, 2025
·
200 min read
·
BioSpace Editorial Staff
Layoffs
Innate Sheds 30% of Staff, Narrows Pipeline Focus Amid ‘Challenging Funding Environment’
September 17, 2025
·
1 min read
·
Tristan Manalac
FDA
FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s
September 17, 2025
·
3 min read
·
Annalee Armstrong